Company: HRTX
Filing Date: 2025-08-28
Form Type: 8-K
Source: 0000950170-25-112048
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-08-28
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Exhibit                                                                                               
  104          Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                             Heron Therapeutics, Inc.                           
  Date: August 28, 2025      /s/ Ira Duarte                                     
                             Ira Duarte                                         
                             Executive Vice President, Chief Financial Officer